Healionics bags $1.7m in first financing round:
This article was originally published in Clinica
Executive Summary
Healionics, a Redmond, Washington-based biomaterials start-up, has secured $1.7m in a series A financing round led by individual private investors. The funds will be used to scale up manufacturing of the firm's STAR (sphere templated angiogenic regenerative) material technology, expand and accelerate preclinical studies of the product and advance the company's business development activities. STAR is designed to enhance biocompatibility of medical devices intended for implantation in the body and to promote healing. Healionics has inked several agreements to apply the STAR material in diabetes, wound care and infusion therapy.